Downloadedfromhttp://ahajournals.orgbyonMarch16,2023CirculationAHASCIENTIFICSTATEMENTEvaluationandManagementofPulmonaryHypertensioninNoncardiacSurgery:AScientificStatementFromtheAmericanHeartAssociationSudarshanRajagopal,MD,PhD,FAHA,ViceChair;KurtRuetzler,MD,PhD,FAHA,Chair;KamrouzGhadimi,MD,MHS,FAHA;EvelynM.Horn,MD;MartaKelava,MD;KristinaT.Kudelko,MD;IngridMoreno-Duarte,MD;IoanaPreston,MD;Leoni...
Downloadedfromhttp://ahajournals.orgbyonMarch30,2023HypertensionAHASCIENTIFICSTATEMENTPediatricPrimaryHypertension:AnUnderrecognizedCondition:AScientificStatementFromtheAmericanHeartAssociationBonitaFalkner,MD,FAHA,Chair;SamuelS.Gidding,MD,FAHA,ViceChair;CarissaM.Baker-Smith,MD,MPH,FAHA;TammyM.Brady,MD,PhD,FAHA;JosephT.Flynn,MD,MS,FAHA;LeslieM.Malle,MSN,FAHA;AndrewM.South,MD,MS,FAHA;AndrewH.Tra...
StrokeAHA/ASAGUIDELINE2023GuidelinefortheManagementofPatientsWithAneurysmalSubarachnoidHemorrhage:AGuidelineFromtheAmericanHeartAssociation/AmericanStrokeAssociationTheAmericanAcademyofNeurologyaffirmsthevalueofthisstatementasaneducationaltoolforneurologists.TheAmericanAssociationofNeurologicalSurgeons/CongressofNeurologicalSurgeonsCerebrovascularSectionaffirmstheeducationalbenefitofthisdocumen...
JOURNALOFTHEAMERICANCOLLEGEOFCARDIOLOGYVOL.-,NO.-,2023ª2023BYTHEAMERICANCOLLEGEOFCARDIOLOGYFOUNDATIONPUBLISHEDBYELSEVIEREXPERTCONSENSUSDECISIONPATHWAY2023ACCExpertConsensusDecisionPathwayonManagementofHeartFailureWithPreservedEjectionFractionAReportoftheAmericanCollegeofCardiologySolutionSetOversightCommitteeWritingMichelleM.Kittleson,MD,PHD,FACC,ChairAnitaDeswal,MD,MPH,FACCCommitteeGurusherS....
JOURNALOFTHEAMERICANCOLLEGEOFCARDIOLOGYVOL.-,NO.-,2023ª2023BYTHEAMERICANCOLLEGEOFCARDIOLOGYFOUNDATIONPUBLISHEDBYELSEVIERAPPROPRIATEUSECRITERIAACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS2023MultimodalityAppropriateUseCriteriafortheDetectionandRiskAssessmentofChronicCoronaryDiseaseAReportoftheAmericanCollegeofCardiologySolutionSetOversightCommittee,AmericanHeartAssociation,AmericanSocietyo...
1前言过去的2023是持续震荡的一年,全球医疗科技IPO都面临挑战,但医疗技术行业在压力之下重塑。为应对资本寒冬和IPO审核收紧带来的压力,国内创新医疗器械企业更加注重商业化。2023年也是行业去伪求真的一年。当共识性、确定性的机会减少,资本收紧不再追逐热门风口,而是下潜洞察细分领域蓝海机会。尽管存在挑战,但是在2023年医疗器械市场仍然存在亮点。国内创新医疗器械企业商业化加速,56款创新医疗器械产品获批,出海成为...
WhitePaperontheDevelopmentofGutIndustry001编委会主编热心肠生物技术研究院创始人/董事长热心肠先生热心肠生物技术研究院《肠道产业》主编蒋刘一琦热心肠生物技术研究院内容中心总编辑王欣热心肠生物技术研究院首席科学家李丹宜主笔蒋刘一琦编委储雪费心筑古丽奴尔何小鹿靳瑾陈国忠秦子鑫沈含洁徐童杨晓满刘潇潇马建爽按姓氏拼音排序支持文雯李健玮谢贺芳陈淑芳李嘉雄介孟恩002声明《2023肠道产业发展白皮书》(以下简称“白...
医药政策系列专题(二)2024年01月24日2023医药政策年度回顾:持续支持,“提质”与监管并重➢医药政策从供给端引导和规范行业发展。近几年围绕医保、医药、医疗“三推荐维持评级医联动”的医疗改革持续推进,行业不断规范发展。其中,医药相关政策从供给端出发,从药品研发、上市审评、合理用药、质量监管等环节全方位引导和规范[Table_Author]行业发展。分析师王班➢创新药:加速审评,研发“提质”。(1)加速审批:2023年3...
Unokietal.JournalofIntensiveCare(2023)11:47JournalofIntensiveCarehttps://doi.org/10.1186/s40560-023-00697-wGUIDELINEOpenAccessJapaneseClinicalPracticeGuidelinesforRehabilitationinCriticallyIllPatients2023(J‑ReCIP2023)TakeshiUnoki1,KeiHayashida2,YusukeKawai3,ShunsukeTaito4,MorihideAndo5,YukiIida6,FumihitoKasai7,TatsuyaKawasaki8,RyoKozu9,72,YutakaKondo10,MasakazuSaitoh11,HideakiSakuramoto12,Nobu...
2023editionwww.strokeguideline.orgContentsWhat’snewinthe2023edition......................................................................................................................4Organisationofstrokeservices..........................................................................................................................4Acutecare.....................................................
WhitePaperTheStateofGlobalClinicalTrialDisclosure:WhatNoncompliancePenaltiesAreinPlace,andHowTheyAreEnforcedMarch2023ContentsIntroduction03IndustryOrganizations04TheGlobalLandscape05InConclusion192March2023Copyright©️2023PharmaIntelligenceUKLimited,aCitelinecompany(Unauthorizedphotocopyingprohibited)IntroductionByDarcyGrabensteinThecoronaviruspandemicputclinicaltrialsinsubmittedlate,and25neve...
2023年度中国医药企业科创力坐标报告CONTENTS012023年中国医药行业的科创领袖企业TOP50是谁?中国医药业科创企业坐标042中国医药业科创企业063医药科创企业08科创企业药09022023年中国医药行业的科创领袖企业TOP50呈现什么特征?中国药112业1131112创13032023年中国医药行业的科创领袖企业TOP50表现如何?科创力152科创193企业2004如何构建2023年中国医药企业科创力坐标?2023年中国医药企业科创力坐标332科创力343科创3605附录...
2023易凯资本中国健康产业白皮书2023易凯资本中国健康产业白皮书数字与AI健康篇2023.042023易凯资本中国健康产业白皮书我国数字医疗市场整体规模(以窄口径计算)从2015年的312亿元增长到了2022年的1792亿元,年复合增长率为28.3%,并且预计在2025年达到4256亿元。其中,2022年医疗信息建设市场份额占比64%,规模接近1158亿元;数字健康服务市场份额占比29%,规模达到511亿元;AI医学影像市场份额占比4.3%,规模接近77亿元;数...